Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Andrew J Shepherd Image

      Andrew J Shepherd, B.Sc. Ph.D.

      Department of Symptom Research, Division of Internal Medicine

      About Dr. Andrew J Shepherd

      Dr. Shepherd is interested in understanding the impact of neuroimmune interactions in chronic pain states. It has been shown that macrophages can profoundly affect the progression of nerve injury and the associated pain. These processes can be influenced by pre-existing systemic inflammation, such as that seen in obesity and certain types of cancer.

      Dr. Shepherd engages in pre-clinical research to elucidate the mechanisms that link inflammation to pain induced by various forms of injury, including joint damage and chemotherapy-induced neuropathy, with a particular focus on signaling related to the renin-angiotensin system. The ultimate goal of this research is to identify interventions that can mitigate or prevent the development of pain associated with these chronic disease states.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Assistant Professor, Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Symptom Research, UT MD Anderson Cancer Center

      Assistant Professor, Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX

      Research Interests

      I have a broad background in neuroimmunology, with training and expertise in rodent models of pain, behavioral readouts of pain sensitivity, learning and memory, and assays of primary rodent and human sensory neuron function. As a postdoc and research-track faculty member, I laid the groundwork for a research effort to understand the involvement of angiotensin-induced signaling events in nerve injury. The research in my own lab covers a broad spectrum of disease states, with a unifying focus on understanding the impact of neuro-immune crosstalk in chronic pain and neurodegeneration. I have an extensive background in rodent neurobehavioral testing (15+ years), which forms a key part of my group's research program. We were recently funded by the Department of Defense for a project focusing on cognitive impairment in colorectal cancer. As co-director of the MD Anderson Rodent Neurobehavioral core facility, I am well-versed in the various behavioral testing strategies, best practices and strengths/limitations of the many approaches that can be used to assess somatosensation, motivation and cognition in rodents. My group also has 10+ years of experience with live-cell functional characterization of peripheral and central nervous system neurons, in terms of calcium flux and electrical activity. Along with expertise in nervous system histology and flow cytometry of leukocytes, we are well equipped to address questions pertaining to neuro-immune crosstalk in pain and neurotoxicity related to cancer and its treatment.

      Education & Training

      Degree-Granting Education

      2014The University of Iowa, Iowa, Iowa, US, Postdoctoral Fellow in Neuropharmacology
      2007The University of Manchester, Manchester, GB, Postdoctoral Fellow in Developmental Neuroscience
      2006The University of Manchester, Manchester, GB, Ph.D. in Neuroimmunomodulation
      2003The University of Manchester Institute of Science & Technology, Manchester, GB, BS in Molecular Cell Biology

      Experience & Service

      Faculty Academic Appointments

      Adjunct Lecturer, Saint Louis University, St. Louis, MO, 2017

      Instructor, Washington University, St. Louis, MO, 2015 - 2018

      Assistant Research Scientist, University of Iowa, Iowa City, IA, 2014

      Course Coordinator, University of Iowa, Iowa City, IA, 2013 - 2014

      Lecturer, University of Iowa, Iowa City, IA, 2012 - 2013

      Postdoctoral Fellow, University of Iowa, Iowa City, IA, 2008 - 2014

      Postdoctoral Research Fellow, University of Manchester, Manchester, 2006 - 2007

      Research Assistant, University of Manchester Institute of Science and Technology, Manchester, 2002 - 2003

      Intramural Institutional Committee Activities

      Co-Director, MD Anderson Pain Research Consortium, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Executive Committee Member, MD Anderson Pain Research Consortium, The University of Texas MD Anderson Cancer Center, 2020 - 2021

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2019 - 2025

      Extramural Institutional Committee Activities

      Chair, Gulf Coast Consortium Translational Pain Research, The University of Texas MD Anderson Cancer Center, 2025 - 2027

      Co-Chair, Gulf Coast Consortium Translational Pain Research, Rice University, 2023 - 2025

      Committee Member, Gulf Coast Consortium Junior Faculty Committee, Rice University, 2021 - 2025

      Committee Member, Gulf Coast Consortium Translational Pain Research, Rice University, 2020 - Present

      Editorial Activities

      Editorial Board Member, Neuroimmunomodulation, 2025 - Present

      Associate Editor, Pain Reports, 2025 - Present

      Honors & Awards

      2024Cyrus Scholar Award, MD Anderson Division of Internal Medicine
      2020Cyrus Scholar Award, MD Anderson Division of Internal Medicine
      2014Young Investigator Travel Award, American Pain Society
      2014Poster Award Winner, University of Iowa Pharmacology Research Retreat
      2012Postdoctoral Fellow Poster Session Winner, University of Iowa Health Sciences Research Week

      Professional Memberships

      United States Association for the Study of Pain

      2020 - Present

      International Association for the Study of Pain

      2018 - Present

      American Pain Society

      2013 - 2018

      American Heart Association

      2010 - Present

      Biophysical Society

      2010

      Society for Neuroscience

      2009 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2026. Neuropathology associated with cancer and its treatment: integration of rodent and non-human primate studies. Panelist. Houston, Texas, US.
      2. 2026. Neuropathology associated with cancer and its treatment: integration of rodent and non-human primate studies. Panelist. Houston, Texas, US.
      3. 2025. Latent neuropathy in colorectal cancer: a CIPN risk factor?. Panelist. MD Anderson Research Town Hall. Houston, Texas, US.
      4. 2025. Colon cancer-driven nerve damage: implications for therapy and survivorship. GSBS Neuroscience program orientation. Houston, Texas, US.
      5. 2025. Cancer Neuroscience Program Update: Milestones & Momentum. Panelist. Houston, Texas, US.
      6. 2025. Inflammatory neuropathy in preclinical models of colorectal cancer. DoIM grand rounds. Houston, Texas, US.
      7. 2024. Neurocognitive assessment. Invited. Houston, Texas, US.
      8. 2024. TTI-101, STAT3 & neuro-immune interactions in chronic pain. Invited. Houston, Texas, US.
      9. 2024. Targeting STAT3 Signaling to Promote Recovery from Neuropathic Pain. Invited. DoIM Research Retreat Cyrus Scholar Award Finalist. Houston, Texas, US.
      10. 2024. Paraneoplastic Neuropathy: Insights from Basic Science. Conference. Pain Management in Cancer Care Symposium. Houston, Texas, US.
      11. 2023. Neuroimmune interactions in chronic pain: models, mechanisms and therapies. Invited. T32 Research Retreat. Iowa City, Iowa, US.
      12. 2022. Angiotensin Signaling and Neuro-Immune Crosstalk in Chronic Pain. Invited. San Diego, CA, US.
      13. 2022. Angiotensin Signaling and Neuro-Immune Crosstalk in Chronic Pain. Invited. San Diego, CA, US.
      14. 2021. Pain due to Cancer and its Treatment: Insights and Novel Therapeutic Targets. Invited. Grand Rounds. Houston, Texas, US.
      15. 2020. Angiotensin Signaling and Neuro-Immune Crosstalk in Chronic Pain. Conference. DoIM Research Retreat Cyrus Scholar Award Finalist. Houston, Texas, US.
      16. 2019. Angiotensin Signaling Augments Oxaliplatin-Induced Neuropathic Pain in a Mouse Model of Colorectal Cancer. Poster. Cancer Research Symposium. Houston, Texas, US.
      17. 2019. Chronic Neuropathic Pain is Mediated by Macrophages and Angiotensin Receptor Signaling. Poster. DoIM Research Retreat. Houston, Texas, US.
      18. 2019. Neuroimmune Interactions in Neuropathic Pain: Involvement of Angiotensin Receptor Signaling. Invited. IBP Seminar Series. Houston, Texas, US.
      19. 2019. Angiotensin Receptor Signaling in Chronic Pain States. Invited. MD Anderson CNI Symposium. Houston, Texas, US.

      Regional Presentations

      1. 2025. Latent neuropathy in colorectal cancer: a CIPN risk factor?. Invited. GCC Translational Pain Research. Houston, Texas, US.
      2. 2023. Repurposing Angiotensin Blockers to Modify Neuroimmune Crosstalk in Neuropathy and Chronic Pain. Invited. AAPS-NERDG. New York, NY, US.
      3. 2023. A mouse model of paraneoplastic neuropathy driven by colorectal cancer. Conference. Translational Pain Research Conference. Houston, TX, US.
      4. 2021. Targeting Neuroimmune Interactions for Relief of Chronic Pain. Invited, US.
      5. 2021. Angiotensin Signaling and Neuro-Immune Crosstalk in Chronic Pain. Invited. Indianapolis, Indiana, US.
      6. 2019. Angiotensin Receptor Signaling in Chronic Pain States. Conference. Translational Pain Research Conference. Houston, TX, US.
      7. 2016. Angiotensin II causes mechanical hypersensitivity via macrophage-derived ROS production. Conference. Angiotensin II causes mechanical hypersensitivity via macrophage-derived ROS production. Austin, TX, US.
      8. 2013. A voltage-gated potassium channel regulates neuronal resilience and death in neuro-HIV infection. Conference. A voltage-gated potassium channel regulates neuronal resilience and death in neuro-HIV infection. San Diego, CA, US.
      9. 2013. PTHrP-TRPV1 signaling axis in pain associated with breast cancer bone metastasis. Conference. PTHrP-TRPV1 signaling axis in pain associated with breast cancer bone metastasis. San Diego, CA, US.
      10. 2013. Complement C5a produces nociceptive sensitization via TRPV1 in mouse. Conference. Complement C5a produces nociceptive sensitization via TRPV1 in mouse. San Diego, CA, US.
      11. 2012. Regulation of neuronal survival-death dynamics via chemokine SDF-1α-induced distinct modulations in Kv2.1 channel. Conference. Regulation of neuronal survival-death dynamics via chemokine SDF-1α-induced distinct modulations in Kv2.1 channel. New Orleans, LA, US.
      12. 2012. Characterization of Ca2+-binding protein 1 (CaBP1) expression and localization in mouse brain. Conference. Characterization of Ca2+-binding protein 1 (CaBP1) expression and localization in mouse brain. New Orleans, LA, US.
      13. 2012. Modulation of TRPV1 activity by PTHrP: A mechanism for pain associated with breast cancer bone metastasis. Conference. Modulation of TRPV1 activity by PTHrP: A mechanism for pain associated with breast cancer bone metastasis. New Orlenas, LA, US.
      14. 2012. Mamba venom natriuretic peptide influences nociceptor sensitization by acting on TRPV1. Conference. Mamba venom natriuretic peptide influences nociceptor sensitization by acting on TRPV1. New Orleans, LA, US.

      National Presentations

      1. 2026. Latent neuropathy in colorectal cancer: implications for cancer survivorship. Invited. Cincinnati, Ohio, US.
      2. 2025. Latent neuropathy in colorectal cancer: implications for cancer survivorship. Invited. Milwaukee, Wisconsin, US.
      3. 2025. Neuro-immune interactions influence chronic pain risk following cancer. Rita Allen Foundation Scholars Symposium. Princeton, New Jersey, US.
      4. 2023. Non-addictive Angiotensin AT2 Inhibitors for Neuropathic Pain Relief. Poster. SfN 2023. Washington, D.C, District of Columbia, US.
      5. 2023. Near-Infrared Fluorescent Nanoemulsion-Based Imaging of Inflammation and Associations with Pain in a Mouse Model of Lower Limb Neuromuscular Polytrauma. Poster. MHSRS 2023. Kissimmee, Florida, US.
      6. 2022. Colon Cancer Augments Sensitivity to Oxaliplatin-Induced Neuropathic Pain. Conference. USASP annual meeting. Cincinnati, Ohio, US.
      7. 2021. Static and Semi-Static Gait Analysis in Rodents. Conference. 2021 Pain in Animals Virtual Workshop. Raleigh, NC, US.
      8. 2021. Angiotensin Signaling and Neuro-Immune Crosstalk in Chronic Pain. Invited. Pittsburgh, PA, US.
      9. 2021. Immune cell tracking in diabetic neuropathy mouse model with NIRF labeled nanoemulsions provides new insights into DPN pain. Poster. MHSRS 2021 (CANCELED). Kissimmee, Florida, US.
      10. 2021. Neuroimmune Interactions in Cancer Pain and Peripheral Neuropathy. Invited. Rita Allen Pain Scholars Symposium, US.
      11. 2021. Neuroimmune Interactions in Cancer Pain and Chemotherapy. Invited. #Pain2021 virtual workshop, US.
      12. 2020. Angiotensin Type 2 Receptor Signaling in Chronic Pain. Invited. Experimental Biology 2020 (CANCELED). San Diego, CA, US.
      13. 2019. AT2R signaling within macrophages underlies chronic neuropathic pain. Poster. Cell Neuroimmune Symposium. Long Beach, California, US.
      14. 2019. Pain hypersensitivity in chronic traumatic neuropathy is mediated by peripheral macrophages and AT2R signaling. Conference. Pain hypersensitivity in chronic traumatic neuropathy is mediated by peripheral macrophages and AT2R signaling. London, England, GB.
      15. 2019. Pain Hypersensitivity in Chronic Traumatic Neuropathy is Mediated by Peripheral Macrophages and AT2R Signaling. Conference. Pain Hypersensitivity in Chronic Traumatic Neuropathy is Mediated by Peripheral Macrophages and AT2R Signaling. Milwaukee, WI, US.
      16. 2019. Macrophage Angiotensin II Type-2 Receptor Triggers Neuropathic Pain. Poster. APS 2019. Milwaukee, Wisconsin, US.
      17. 2019. Pain hypersensitivity in chronic traumatic neuropathy is mediated by peripheral macrophages and AT2R signaling. Conference. Pain hypersensitivity in chronic traumatic neuropathy is mediated by peripheral macrophages and AT2R signaling. Milwaukee, WI, US.
      18. 2017. Macrophage Angiotensin II Type-2 (AT2R) Receptor is Critical for Neuropathic Pain. Conference. Macrophage Angiotensin II Type-2 (AT2R) Receptor is Critical for Neuropathic Pain. Washington, DC, US.
      19. 2017. Mechanisms of thermal and mechanical hyperalgesia induced by the complement system component C5a: the role of macrophages and TRPV1. Conference. Mechanisms of thermal and mechanical hyperalgesia induced by the complement system component C5a: the role of macrophages and TRPV1. Washington, DC, US.
      20. 2017. Intercellular Redox Signaling Between Macrophage AT2R and Sensory Neuron TRPA1 Mediates Nociceptor Excitation. Conference. Intercellular Redox Signaling Between Macrophage AT2R and Sensory Neuron TRPA1 Mediates Nociceptor Excitation. Washington, DC, US.
      21. 2016. NGF and CNP induce mechanical hypersensitivity and hyperalgesic priming through distinct signaling mechanisms converging on TRPV1 and TRPA1 channels. Conference. NGF and CNP induce mechanical hypersensitivity and hyperalgesic priming through distinct signaling mechanisms converging on TRPV1 and TRPA1 channels. Austin, TX, US.
      22. 2016. Molecular, Cellular and Anatomical Mechanisms Underlying Peripheral Detection of Painful Stimuli in Injury and Inflammation. Conference. Molecular, Cellular and Anatomical Mechanisms Underlying Peripheral Detection of Painful Stimuli in Injury and Inflammation. Breckenridge, CO, US.
      23. 2015. Distinct Pathways Underlying Peripheral Thermal and Mechanical Hypersensitivity Induced by C-type Natriuretic Peptide. Conference. Distinct Pathways Underlying Peripheral Thermal and Mechanical Hypersensitivity Induced by C-type Natriuretic Peptide. Chicago, IL, US.
      24. 2015. AT2-ROS signaling induces peripheral mechanical, but not thermal hypersensitivity elicited by Angiotensin-II. Conference. AT2-ROS signaling induces peripheral mechanical, but not thermal hypersensitivity elicited by Angiotensin-II. Palm Springs, CA, US.
      25. 2014. Nociceptor sensitization by PTHrP: a mechanism for pain associated with breast cancer bone metastasis. Conference. Nociceptor sensitization by PTHrP: a mechanism for pain associated with breast cancer bone metastasis. Tampa, FL, US.
      26. 2014. Distinct pathways underlying pain hypersensitivity caused by Ctype natriuretic peptide. Conference. Distinct pathways underlying pain hypersensitivity caused by Ctype natriuretic peptide. Tampa, FL, US.
      27. 2013. Distinct Pathways Underlying Pain Hypersensitivity Caused by C-Type Natriuretic Peptide. Conference. Distinct Pathways Underlying Pain Hypersensitivity Caused by C-Type Natriuretic Peptide. Cincinnati, OH, US.

      International Presentations

      1. 2026. Neuropathy in Colorectal Cancer: Implications for CIPN. Invited. PORT for Health: Oncology 2026. Wroclaw, PL.
      2. 2024. Fibroblast control of macrophage phenotype in chronic pain states. Conference. IASP 2024. Amsterdam, NL.
      3. 2024. Fibroblast Control of Macrophage Phenotype in Chronic Pain States. Invited. MCSA-ETN PIANO 3rd Annual Meeting and Conference. Elche, ES.
      4. 2022. Neuroimmune interactions & Ang II Receptor Signaling: Neuropathic Pain and Beyond. Conference. IASP 2022. Toronto, CA.
      5. 2022. Angiotensin Signaling and Neuro-immune Crosstalk in Chronic Pain. Invited. Aachen, DE.
      6. 2022. Angiotensin Signaling and Neuro-immune Interactions in Chronic Pain States. Conference. Pain Mechanisms and Therapeutics Conference. Verona, IT.
      7. 2019. Unevoked Measures of Pain Sensitivity in Mice: One Scientist’s Experience. Invited. Espoo, FI.

      Formal Peers

      1. 2023. Neuro-immune Interactions in Chronic Pain. Houston, Texas, US.
      2. 2023. Paraneoplastic Neuropathy in Colorectal Cancer: Preclinical findings and implications for therapy. Houston, Texas, US.
      3. 2022. Macrophages as Drivers of Chronic Pain. Houston, Texas, US.
      4. 2018. Angiotensin II and Neuroimmune Crosstalk in Neuropathic Pain. Invited. London, England, GB.
      5. 2013. Intrinsic Regulation of Survival and Death in Mammalian Brain Neurons: a Potassium Channel Holds the Key. Invited. Manchester, GB.
      Read More
      Less

      Grant & Contract Support

      Date: 2024 - 2027
      Title:Understanding NRF2 repression in malignant peripheral nerve sheath tumor (MPNST) growth and pain
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP240220
      Date: 2023 - 2028
      Title:Integrated Mechanisms and Phenotypes of Chronic Post-Surgical Pain
      Funding Source:Washington University St Louis
      Role:Co-PI
      ID:FP00018728
      Date: 2023 - 2026
      Title:Epigenetic Modification of Macrophages by Targeted Nanoparticles for Sustained Relief in Post-Trauma Chronic Pain
      Funding Source:Department of Defense (DOD)
      Role:PI
      ID:FP00017594
      Date: 2023 - 2028
      Title:Injectable nonopioid microtherapeutic for sustained pain control
      Funding Source:Baylor College of Medicine
      Role:Co-I
      ID:R01 DA058651
      Date: 2022 - 2027
      Title:Development of Pathology-activated Drugs for Treatment of Neuropathic Pain
      Funding Source:NIH/NINDS
      Role:Co-I
      ID:UG3 NS127251-01A1
      Date: 2022 - 2027
      Title:Myeloid-Targeted Epigenetic Modification to Mitigate Chronic Pain Risk Post- Sepsis
      Funding Source:NIH/NINDS
      Role:PI
      ID:R01 NS129561
      Date: 2022 - 2025
      Title:Targeting STAT3 Signaling to Promote Recovery from Neuropathic Pain
      Funding Source:Department of Defense (DOD)
      Role:PI
      ID:W81XWH-21-CPMRP-IIRA
      Date: 2022 - 2025
      Title:Ferroptosis Inhibiting Osteoarthritis Nano‐Analgesic (FIONA) Platform as an Intraarticular Disease Modifying Treatment Strategy
      Funding Source:Duquesne University
      Role:PI
      ID:W81XWH-21-PRMRP-IIRA
      Date: 2022 - 2027
      Title:Angiotensin Signaling Underlies Myeloid and Sensory Disruption in Diabetes
      Funding Source:NIH/NIDDK
      Role:PI
      ID:R01 DK 132019
      Date: 2022 - 2026
      Title:Development of Pathology-Activated Prodrugs for Non-Opioid Treatment of Chronic Pain
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:Co-I
      ID:FP00014533
      Date: 2022 - 2027
      Title:Development of Pathology activated Drugs for Treatment of Neuropathic Pain
      Funding Source:NIH/NINDS
      Role:Co-I
      ID:1 UG3 NS127251 - 01
      Date: 2022 - 2027
      Title:Role of Angiotensin II in Bladder Dysfunction and Fibrosis
      Funding Source:University of Florida
      Role:Principal Investigator-MDACC
      ID:FP00013657
      Date: 2021 - 2026
      Title:Neuroimmune Crosstalk in Neuropathy Mediated by Angiotensin Receptor Signaling
      Funding Source:NIH/NINDS
      Role:PI
      ID:1 R01 NS124737 -01
      Date: 2021 - 2024
      Title:Targeting Angiotensin-Based Neuroimmune Crosstalk for Treatment of Neuromuscular Trauma
      Funding Source:Department of Defense (DOD)
      Role:PI
      ID:W81-XWH-2110197
      Date: 2021 - 2026
      Title:Angiotensin Receptor Signaling in Neuropathic Pain States
      Funding Source:NIH/NCI
      Role:PI
      ID:1 R01 NS117760-01
      Date: 2021 - 2023
      Title:Co-Morbid Depression in Chronic Pain: The Role of Angiotensin AT2 Receptor Signaling
      Funding Source:Brain and Behavior Research Foundation
      Role:PI
      ID:FP00010633
      Date: 2020 - 2021
      Title:Angiotensin Signaling and Neuro-Immune Crosstalk in Chemotherapy-Induced Neuropathic Paiin
      Funding Source:UT MDACC Adverse Incident Bridge Funding
      Role:PI
      ID:00059224
      Date: 2020 - 2023
      Title:Angiotensin Receptor Signaling Augments Oxaliplatin-Induced Neuropathic Pain
      Funding Source:The University of Texas MD Anderson Cancer Center DoIM
      Role:PI
      Date: 2020 - 2021
      Title:Angiotensin Signaling and Neuro-Immune Crosstalk in Chemotherapy-Induced Neuropathic Pain
      Funding Source:The University of Texas MD Anderson Cancer Center
      Role:PI
      Date: 2020 - 2024
      Title:Validation of Fibroblast-Derived PI16 as a Novel Target for Pain Treatment
      Funding Source:NIH/NINDS
      Role:PI
      ID:R01 NS116704
      Date: 2020 - 2023
      Title:Neuro-immune Interactions in Pain Associated with Cancer and Chemotherapy
      Funding Source:Rita Allen Foundation Scholars Program
      Role:PI
      ID:FP00010350
      Date: 2020 - 2021
      Title:Angiotensin Drives Inflammation and Chronic Bone Pain in Metastatic Prostate Cancer
      Funding Source:The University of Texas MD Anderson Cancer Center IRG
      Role:PI
      ID:00058865
      Date: 2020 - 2022
      Title:Angiotensin II: a Dual Trigger of Macrophage-Driven Neuropathy in Chemotherapy
      Funding Source:Andrew Sabin Family Foundation Award
      Role:PI
      Date: 2020 - 2022
      Title:Angiotensin Links Obesity to Osteoarthritis Pain via Neuroimmune
      Funding Source:Department of Defense (DOD)
      Role:PI
      ID:W81XWH-19-PRMRP-DA
      Date: 2020 - Present
      Title:Neuro-Immuno Modulating Analgesic (NiMA) Nanomedicine Platform for Treatment of Diabetic Neuropathy
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:Co-PI
      ID:W81XWH-20-1-0277
      Date: 2020 - 2025
      Title:Angiotensin Signaling and Neuro-immune Crosstalk in Neuropathic Pain States
      Funding Source:NIH/NINR
      Role:PI
      ID:R01NS117760
      Date: 2020 - 2023
      Title:Angiotensin Signaling Drives Inflammation and Pain in Obesity and Type 2 Diabetes
      Funding Source:American Heart Association
      Role:PI
      ID:FP00010109
      Date: 2020 - 2025
      Title:Non-Addictive Angiotensin AT2 Inhibitors for Neuropathic Pain Relief
      Funding Source:University of Southern California
      Role:Co-PI
      ID:UH3 NS116929
      Date: 2020 - 2025
      Title:Neuroimmune Crosstalk Augments Osteoarthritis Pain in Obesity
      Funding Source:NIH/NINDS
      Role:PI
      ID:R01AR077343
      Date: 2020 - 2022
      Title:Meningeal Immunity: A Neuroinflammatory Nexus
      Funding Source:Chan Zuckerberg Inittiative
      Role:Co-PI
      ID:FP00009818
      Date: 2019 - 2024
      Title:Nrf2 Activation for Addiction-Free Treatment of Neuropathic Pain
      Funding Source:NIH/NINDS
      Role:Co-I
      ID:RF1NS113840
      Date: 2019 - 2020
      Title:Angiotensin II Augments Oxaliplatin-Induced Neuropathy in Colorectal Cancer
      Funding Source:The University of Texas MD Anderson Cancer Center Institutional Research Grant Application
      Role:PI
      Date: 2019 - 2020
      Title:Angiotensin Links Obesity to Osteoarthritis Pain via Neuroimmune Crosstalk
      Funding Source:Arthritis National Research Foundation
      Role:PI
      ID:FP00007258
      Date: 2019 - 2023
      Title:PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain (Admin Suppl)
      Funding Source:NIH/NCI
      Role:PI
      ID:3 R01 CA227064-02S1
      Date: 2019 - 2022
      Title:University of Texas System Rising STARs Award
      Funding Source:The University of Texas System Faculty Science and Technology Acquisition and Retention (STARs) program
      Role:PI
      Date: 2018 - 2024
      Title:PQ12 Targeting HDAC6 for Chemotherapy Induced Neuropathy and Chemobrain
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01CA227064
      Date: 2017 - 2018
      Title:Angiotensin Links Osteoarthritis Pain to Obesity via Macrophages and TRPA1
      Funding Source:Washington University Nutrition Obesity Research Center
      Role:PI
      ID:P30DK056341
      Date: 2017 - 2022
      Title:PQ9 Mesenchymal Stem Cells to Repair Chemobrain
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01 CA208371
      Date: 2016 - 2022
      Title:Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain
      Funding Source:NIH/NINDS
      Role:Co-I
      ID:R01 NS073939

      Selected Publications

      Peer-Reviewed Articles

      1. Pandey, V, Acharya, TK, Willcox, K, Dembla, S, Ramanujan, A, Grieco, AR, Zuberi, YA, Mahalingam, R, Shepherd, AJ, Heijnen, CJ, Grace, P. Peripheral nerve injury reduces macrophage efferocytosis to facilitate neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America 123(1), 2026. e-Pub 2026. PMID: 41481465.
      2. Mohan P, Sobhanan J, Gaffney CM, Mehrotra N, Cabrera FJ, Lee R, Adumbumkulath A, Haas E, Shepherd AJ, Shin CS, Acharya G. Local Delivery of Non-opioid Analgesic Microparticles to Modulate Post-surgical Pain. Pharm Res 42(9):1573-1585, 2025. e-Pub 2025. PMID: 40903542.
      3. Vichare R, Kulahci Y, McCallin R, Zor F, Selek FN, Liu L, Crelli C, Troidle A, Herneisey M, Nichols JM, Shepherd AJ, Gorantla VS, Janjic JM. Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats. J Nanobiotechnology 23(1):80, 2025. e-Pub 2025. PMID: 39905487.
      4. McIlvried, LA, Del Rosario, JS, Pullen, MY, Wanghzou, A, Sheahan, TD, Shepherd, AJ, Slivicki, RA, Lemen, JA, Price, TJ, Copits, BA, Gereau IV, RW. Intrinsic adaptive plasticity in mouse and human sensory neurons. Journal of General Physiology 157(1), 2025. e-Pub 2025. PMID: 39688836.
      5. Avery TD, Li J, Turner DJL, Rasheed MSU, Cherry FR, Stachura DL, Rivera-Escalera F, Ruiz DM, Lacagnina MJ, Gaffney CM, Aguilar C, Yu J, Wang Y, Xie H, Liang D, Shepherd AJ, Abell AD, Grace PM. Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders. Nat Biotechnol 43(10):1624-1627, 2024. e-Pub 2024. PMID: 39496929.
      6. Das AC, Nichols JM, Crelli CV, Liu L, Vichare R, Pham HV, Gaffney CM, Cherry FR, Grace PM, Shepherd AJ, Janjic JM. Injectable, reversibly thermoresponsive captopril-laden hydrogel for the local treatment of sensory loss in diabetic neuropathy. Sci Rep 14(1):18978, 2024. e-Pub 2024. PMID: 39152212.
      7. Nichols JM, Pham HV, Lee EF, Mahalingam R, Shepherd AJ. Single-cell analysis of age-related changes in leukocytes of diabetic mouse hindpaws. Cell Mol Life Sci 81(1):146, 2024. e-Pub 2024. PMID: 38502310.
      8. Cortez, I, Gaffney, CM, Crelli, CV, Lee, E, Nichols, JM, Pham, HV, Mehdi, S, Janjic, JM, Shepherd, AJ. Sustained pain and macrophage infiltration in a mouse muscle contusion model. Muscle and Nerve 69(1):103-114, 2024. e-Pub 2024. PMID: 37929655.
      9. Cortez I, Gaffney CM, Vichare R, Crelli CV, Liu L, Lee E, Edralin J, Nichols JM, Pham HV, Mehdi S, Janjic JM, Shepherd AJ. Neuromuscular Polytrauma Pain is Resolved by Macrophage COX-2 Nanoimmunomodulation. Int J Nanomedicine 19:7253-7271, 2024. e-Pub 2024. PMID: 39050880.
      10. Garrity R, Arora N, Haque MA, Weis D, Trinh RT, Neerukonda SV, Kumari S, Cortez I, Ubogu EE, Mahalingam R, Tavares-Ferreira D, Price TJ, Kavelaars A, Heijnen CJ, Shepherd AJ. Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206+ myeloid cells. Brain Behav Immun 112:220-234, 2023. e-Pub 2023. PMID: 37315702.
      11. McIlvried LA, Del Rosario JS, Pullen MY, Wangzhou A, Sheahan TD, Shepherd AJ, Slivicki RA, Lemen JA, Price TJ, Copits BA, Gereau RW. Intrinsic Homeostatic Plasticity in Mouse and Human Sensory Neurons. bioRxiv, 2023. e-Pub 2023. PMID: 37398430.
      12. Robilotto GL, Mohapatra DP, Shepherd AJ, Mickle AD. Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1. Eur J Pain 26(9):1967-1978, 2022. e-Pub 2022. PMID: 35900227.
      13. Balogh M, Zhang J, Gaffney CM, Kalakuntla N, Nguyen NT, Trinh RT, Aguilar C, Pham HV, Milutinovic B, Nichols JM, Mahalingam R, Shepherd AJ. Sensory neuron dysfunction in orthotopic mouse models of colon cancer. J Neuroinflammation 19(1):204, 2022. e-Pub 2022. PMID: 35962398.
      14. Gaffney CM, Muwanga G, Shen H, Tawfik VL, Shepherd AJ. Mechanical Conflict-Avoidance Assay to Measure Pain Behavior in Mice. J Vis Exp 2022(180), 2022. e-Pub 2022. PMID: 35253785.
      15. Balogh M, Janjic JM, Shepherd AJ. Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine. Antioxid Redox Signal 36(1-3):122-143, 2022. e-Pub 2022. PMID: 34416821.
      16. Nichols JM, Crelli CV, Liu L, Pham HV, Janjic JM, Shepherd AJ. Tracking macrophages in diabetic neuropathy with two-color nanoemulsions for near-infrared fluorescent imaging and microscopy. J Neuroinflammation 18(1):299, 2021. e-Pub 2021. PMID: 34949179.
      17. English K, Shepherd A, Uzor NE, Trinh R, Kavelaars A, Heijnen CJ. Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer. Acta Neuropathol Commun 8(1):36, 2020. e-Pub 2020. PMID: 32197663.
      18. Shepherd, AJ, Mohapatra, DP. Attenuation of Unevoked Mechanical and Cold Pain Hypersensitivities Associated with Experimental Neuropathy in Mice by Angiotensin II Type-2 Receptor Antagonism. Anesthesia and analgesia 128(6):E84-E87, 2019. e-Pub 2019. PMID: 31094778.
      19. Warwick CA, Shutov LP, Shepherd AJ, Mohapatra DP, Usachev YM. Mechanisms underlying mechanical sensitization induced by complement C5a: the roles of macrophages, TRP channels and CGRP receptors. Pain 160(3):702-711, 2019. e-Pub 2019. PMID: 30507785.
      20. Shepherd AJ, Mickle AD, Golden JP, Mack MR, Halabi CM, de Kloet AD, Samineni VK, Kim BS, Krause EG, Gereau RW, Mohapatra DP. Macrophage Angiotensin II type-2 Receptor Triggers Neuropathic Pain. Proc Natl Acad Sci U S A 115(34):E8057-E8066, 2018. e-Pub 2018. PMID: 30082378.
      21. Shepherd AJ, Copits BA, Mickle AD, Karlsson P, Kadunganattil S, Haroutounian S, Tadinada SM, de Kloet AD, Valtcheva MV, McIlvried LA, Sheahan TD, Jain S, Ray PR, Usachev YM, Dussor G, Krause EG, Price TJ, Gereau RW, Mohapatra DP. Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci 38(32):7032-7057, 2018. e-Pub 2018. PMID: 29976627.
      22. Shepherd AJ, Mickle AD, McIlvried LA, Gereau RW, Mohapatra DP. Parathyroid hormone-related peptide activates and modulates TRPV1 channel in human DRG neurons. European Journal of Pain 22(9):1685-1690, 2018. e-Pub 2018. PMID: 29797679.
      23. Shepherd AJ, Mohapatra DP. Pharmacological validation of voluntary gait and mechanical sensitivity assays associated with inflammatory and neuropathic pain in mice. Neuropharmacology 130:18-29, 2018. e-Pub 2018. PMID: 29191755.
      24. Shepherd AJ, Mickle AD, Kadunganattil S, Hu H, Mohapatra DP. Parathyroid hormone-related peptide elicits peripheral TRPV1-dependent mechanical hypersensitivity. Front Cell Neurosci 12:38, 2018. e-Pub 2018. PMID: 29497363.
      25. Shepherd AJ, Cloud ME, Cao YQ, Mohapatra DP. Deficits in burrowing behaviors are indicative of neuropathic but not inflammatory pain or migraine in mice. Front Behav Neurosci 12:124, 2018. e-Pub 2018. PMID: 30002622.
      26. Sheahan TD, Siuda ER, Bruchas MR, Shepherd AJ, Mohapatra DP, Gereau RW, Golden JP. Inflammation and nerve injury minimally affect mouse voluntary behaviors proposed as indicators of pain. Neurobiol Pain 2:1-12, 2017. e-Pub 2017. PMID: 29075674.
      27. Shutov LP, Warwick CA, Shi X, Gnanasekaran A, Shepherd AJ, Mohapatra DP, Woodruff TM, Clark JD, Usachev YM. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1. J Neurosci 36(18):5055-70, 2016. e-Pub 2016. PMID: 27147658.
      28. Gupte RP, Kadunganattil S, Shepherd AJ, Merrill R, Planer W, Bruchas MR, Strack S, Mohapatra DP. Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide. Neuropharmacology 101:291-308, 2016. e-Pub 2016. PMID: 26456351.
      29. Mickle AD, Shepherd AJ, Loo L, Mohapatra DP. Induction of thermal and mechanical hypersensitivity by parathyroid hormone-related peptide through upregulation of TRPV1 function and trafficking. Pain 156(9):1620-36, 2015. e-Pub 2015. PMID: 25970319.
      30. Kim KY, Scholl ES, Liu X, Shepherd A, Haeseleer F, Lee A. Localization and expression of CaBP1/caldendrin in the mouse brain. Neuroscience 268:33-47, 2014. e-Pub 2014. PMID: 24631676.
      31. Sowers LP, Loo L, Wu Y, Campbell E, Ulrich JD, Wu S, Paemka L, Wassink T, Meyer K, Bing X, El-Shanti H, Usachev YM, Ueno N, Manak JR, Manak RJ, Shepherd AJ, Ferguson PJ, Darbro BW, Richerson GB, Mohapatra DP, Wemmie JA, Bassuk AG. Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction. Mol Psychiatry 18(10):1077-89, 2013. e-Pub 2013. PMID: 23711981.
      32. Hall DD, Dai S, Tseng PY, Malik Z, Nguyen M, Matt L, Schnizler K, Shephard A, Mohapatra DP, Tsuruta F, Dolmetsch RE, Christel CJ, Lee A, Burette A, Weinberg RJ, Hell JW. Competition between α-actinin and Ca²?-calmodulin controls surface retention of the L-type Ca²? channel Ca(V)1.2. Neuron 78(3):483-97, 2013. e-Pub 2013. PMID: 23664615.
      33. Shepherd AJ, Loo L, Mohapatra DP. Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure. PLoS One 8(9):e76698, 2013. e-Pub 2013. PMID: 24086760.
      34. Shepherd AJ, Loo L, Gupte RP, Mickle AD, Mohapatra DP. Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics. J Neurosci 32(49):17725-39, 2012. e-Pub 2012. PMID: 23223293.
      35. Loo L, Shepherd AJ, Mickle AD, Lorca RA, Shutov LP, Usachev YM, Mohapatra DP. The C-type natriuretic peptide induces thermal hyperalgesia through a noncanonical Gβγ-dependent modulation of TRPV1 channel. J Neurosci 32(35):11942-55, 2012. e-Pub 2012. PMID: 22933780.
      36. Maity B, Stewart A, Yang J, Loo L, Sheff D, Shepherd AJ, Mohapatra DP, Fisher RA. Regulator of G protein signaling 6 (RGS6) protein ensures coordination of motor movement by modulating GABAB receptor signaling. J Biol Chem 287(7):4972-81, 2012. e-Pub 2012. PMID: 22179605.
      37. Shepherd AJ, Mohapatra DP. Tissue preparation and immunostaining of mouse sensory nerve fibers innervating skin and limb bones. J Vis Exp(59):e3485, 2012. e-Pub 2012. PMID: 22314687.
      38. Yang J, Huang J, Maity B, Gao Z, Lorca RA, Gudmundsson H, Li J, Stewart A, Swaminathan PD, Ibeawuchi SR, Shepherd A, Chen CK, Kutschke W, Mohler PJ, Mohapatra DP, Anderson ME, Fisher RA. RGS6, a modulator of parasympathetic activation in heart. Circ Res 107(11):1345-9, 2010. e-Pub 2010. PMID: 20864673.
      39. Cains S, Shepherd A, Nabiuni M, Owen-Lynch PJ, Miyan J. Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus. J Neuropathol Exp Neurol 68(4):404-16, 2009. e-Pub 2009. PMID: 19287311.
      40. Shepherd AJ, Beresford LJ, Bell EB, Miyan JA. Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P. J Neuroimmunol 164(1-2):115-23, 2005. e-Pub 2005. PMID: 15899523.

      Review Articles

      1. Sur D, Zeng Y, Kobayashi H, Zhi X, Goetz MR, Muller CM, Zavitsanou AM, Picoli CC, Martel Matos AA, Pareja J, Savita BK, Lee T, Cunha-Junior JP, Amorim JH, Nikpoor AR, Dory A, Thanabalasuriar A, Galante PAF, Ma VT, James AW, Shepherd AJ, Oudin MJ, Bunimovich YL, Scheff NN, D'Silva NJ, Dixon KO, Abdus-Saboor I, Wang TC, Talbot S, Birbrair A. Entangled cellular and molecular relationships at the sensory neuron-cancer interface. Neuron 113(17):2760-2790, 2025. e-Pub 2025. PMID: 40907473.
      2. Shepherd, AJ, Rice, AS, Smith, MT. Angiotensin II type 2 receptor signalling as a pain target. Current Opinion in Pharmacology 73, 2023. e-Pub 2023. PMID: 38041933.
      3. Balogh M, Aguilar C, Nguyen NT, Shepherd AJ. Angiotensin receptors and neuropathic pain. Pain Rep 6(1):e869, 2021. e-Pub 2021. PMID: 33981922.
      4. Du KN, Shepherd AJ, Ma IV, Roldan CJ, Amit M, Feng LMS, Desai S, Cata JP. Lack of association between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and pain improvement in patients with oral cancer. Ecancermedicalscience 14:1121, 2020. e-Pub 2020. PMID: 33209112.
      5. Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic Pain: Central vs. Peripheral Mechanisms. Curr Pain Headache Rep 21(6):28, 2017. e-Pub 2017. PMID: 28432601.
      6. Mickle AD, Shepherd AJ, Mohapatra DP. Nociceptive TRP Channels: Sensory Detectors and Transducers in Multiple Pain Pathologies. Pharmaceuticals (Basel) 9(4), 2016. e-Pub 2016. PMID: 27854251.
      7. Mickle AD, Shepherd AJ, Mohapatra DP. Sensory TRP channels: the key transducers of nociception and pain. Prog Mol Biol Transl Sci 131:73-118, 2015. e-Pub 2015. PMID: 25744671.
      8. Shepherd AJ, Downing JE, Miyan JA. Without nerves, immunology remains incomplete -in vivo veritas. Immunology 116(2):145-63, 2005. e-Pub 2005. PMID: 16162264.

      Other Articles

      1. Sur, D, Zeng, Y, Kobayashi, H, Zhi, X, Goetz, MR, Müller, CM, Zavitsanou, AM, Picoli, CC, Martel Matos, AA, Pareja, J, Savita, BK, Lee, T, Cunha-Junior, JP, Amorim, JH, Nikpoor, AR, Dory, A, Thanabalasuriar, A, Galante, PA, Ma, VT, James, A, Shepherd, AJ, Oudin, M, Bunimovich, YL, Scheff, NN, D'Silva, NJ, Dixon, KO, Abdus-Saboor, I, Wang, TC, Talbot, S, Birbrair, A Erratum. Neuron 113(20):3491, 2025. PMID: 41016393.
      2. Sowers, LP, Loo, L, Wu, Y, Campbell, E, Ulrich, JD, Wu, S, Paemka, L, Wassink, T, Meyer, K, Bing, X, El-Shanti, H, Usachev, YM, Ueno, N, Manak, RJ, Shepherd, AJ, Ferguson, PJ, Darbro, B, Richerson, GB, Mohapatra, DP, Wemmie, JA, Bassuk, AG Erratum. Molecular psychiatry 19(6):742, 2014.

      Abstracts

      1. Mohapatra DP, Loo L, Lorca R, Shepherd A, Usachev Y, Yorek M. Modulation of TRPV1 and TTXr-Na+ channels by natriuretic peptides and IL6 family cytokines: a mechanism for cardiac nociceptive reflex. APS 2011 12(S4):P30, 2011. e-Pub 2011.
      2. Vaddi S, Rasul S, Cains S, Shepherd A, Bannister C. Comparison of key interhemispheric connections and the posterior commissure in normal and hydrocephalic rat fetuses. 52nd Annual Meeting of the Society for Research into Hydrocephalus and Spina Bifida 6(S1):S8, 2009. e-Pub 2009.
      3. Stewart A, Maity B, Yang J, Loo L, Shepherd AJ, Mohapatra DP, Fisher RA. Regulator of G Protein Signaling 6 (RGS6) ensures coordination of motor movement by modulating GABAB Receptor (GABABR) signaling. Experimental Biology 2012.
      4. Shepherd A, Mohapatra DP. Are Voltage-gated Potassium (Kv) Channels Recruited Into Lipid Rafts In Mammalian Brain Neurons?. Biophysical Society 53rd Annual Meeting 96(3):560A-561A.
      5. Mickle A, Shepherd A, Loo L, Mohapatra DP. Nociceptor sensitization by PTHrP: a mechanism for pain associated with breast cancer bone metastasis. APS 2014.

      Book Chapters

      1. Casaril, A, Gaffney, CM, Shepherd, AJ. Animal models of neuropathic pain, 339-401, 2024.
      2. Janjic JM, Balogh M, Reddy Adena SK, Fitzpatrick A, Pollock JA, Gorantla V, Shepherd AJ. Targeted Imaging and Therapeutic Technologies in Neuroregeneration. In: Reconstructive Transplantation and Regenerative Medicine: The Emerging Interface. CRC Press, 2021.
      3. Bocksteins E, Shepherd AJ, Mohapatra DP, Snyders DJ. Immunostaining of Voltage-Gated Ion Channels in Cell Lines and Neurons–Key Concepts and Potential Pitfalls. In: Applications of Immunocytochemistry. IntechOpen, 2012.

      Letters to the Editor

      1. Shepherd AJ. Response to comment on: Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206(+) myeloid cells. Brain Behav Immun 117: 312, 2024.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Shepherd Laboratory

      • Symptom Research department

      • Internal Medicine division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top